Dynamic effects of antibody-dependent enhancement on the fitness of viruses
- 10 October 2005
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (42) , 15259-15264
- https://doi.org/10.1073/pnas.0507320102
Abstract
Antibody-dependent enhancement (ADE), a phenomenon in which viral replication is increased rather than decreased by immune sera, has been observed in vitro for a large number of viruses of public health importance, including flaviviruses, coronaviruses, and retroviruses. The most striking in vivo example of ADE in humans is dengue hemorrhagic fever, a disease in which ADE is thought to increase the severity of clinical manifestations of dengue virus infection by increasing virus replication. We examine the epidemiological impact of ADE on the prevalence and persistence of viral serotypes. Using a dynamical system model of n cocirculating dengue serotypes, we find that ADE may provide a competitive advantage to those serotypes that undergo enhancement compared with those that do not, and that this advantage increases with increasing numbers of cocirculating serotypes. Paradoxically, there are limits to the selective advantage provided by increasing levels of ADE, because greater levels of enhancement induce large amplitude oscillations in incidence of all dengue virus infections, threatening the persistence of both the enhanced and nonenhanced serotypes. Although the models presented here are specifically designed for dengue, our results are applicable to any epidemiological system in which partial immunity increases pathogen replication rates. Our results suggest that enhancement is most advantageous in settings where multiple serotypes circulate and where a large host population is available to support pathogen persistence during the deep troughs of ADE-induced large amplitude oscillations of virus replication.Keywords
This publication has 38 references indexed in Scilit:
- Chaotic desynchronization of multistrain diseasesPhysical Review E, 2005
- Cost-effectiveness of a pediatric dengue vaccineVaccine, 2004
- Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strainsProceedings Of The Royal Society B-Biological Sciences, 2003
- Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic feverNature Medicine, 2003
- Ecological interference between fatal diseasesNature, 2003
- Evolutionary trade–offs at two time–scales: competition versus persistenceProceedings Of The Royal Society B-Biological Sciences, 2000
- Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease SeverityThe Journal of Infectious Diseases, 2000
- Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic feverThe Lancet, 1999
- Transmission dynamics and epidemiology of dengue: insights from age–stratified sero–prevalence surveysPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1999
- A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodiesArchiv für die gesamte Virusforschung, 1991